From January 1, 2021 to October 13, 2022, the company has repurchased 150,077 shares, representing 1.26% for KRW 17,931.3 million. With this, the company has completed the repurchase of 160,533 shares, representing 1.35% for KRW 19,569.85 million under the buyback announced on October 15, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
106,000 KRW | +6.00% | +2.81% | -19.02% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.02% | 933M | |
+18.04% | 43.07B | |
+16.92% | 21.51B | |
+18.33% | 15.19B | |
+19.27% | 14.44B | |
+56.12% | 13.12B | |
-10.73% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+4.00% | 4.73B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 15, 2020.